Copyright
©The Author(s) 2021.
World J Hepatol. Dec 27, 2021; 13(12): 1991-2004
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.1991
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.1991
Figure 1 Overview of approach and management of post liver transplant metabolic dysfunction-associated fatty liver disease patients.
USG: Ultrasound; CT: Computed tomography; TE: Transient elastography; MRS: Magnetic resonance spectroscopy; MRI-PDFF: Magnetic resonance imaging-proton density fat fraction; SWE: Shear wave elastography; MRE: Magnetic resonance elastography.
- Citation: Han MAT, Olivo R, Choi CJ, Pyrsopoulos N. De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation. World J Hepatol 2021; 13(12): 1991-2004
- URL: https://www.wjgnet.com/1948-5182/full/v13/i12/1991.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i12.1991